98%
921
2 minutes
20
We are reporting for the first time the synthesis and application of an innovative nanometric system for the controlled topic release of melatonin in the retina. The ethylcellulose nanocapsules were characterized by diverse physicochemical techniques (scanning electron microscopy, zeta potential, hydrodynamic diameters) and an in vitro release study was done. A complete ex vivo and in vivo trans-corneal permeation and an irritation study were carried out with the new formulations in albino rabbits, to which a retinal degenerative model was induced. The results obtained demonstrate that the in vitro release of melatonin (1 mg/mL and 2 mg/mL) transported by nanocapsules is slower when compared to a solution of melatonin. Greater penetration of melatonin through the cornea was demonstrated by ex vivo and in vivo tests. This can be attributable to an enhanced neuroprotective effect of melatonin on retinal ganglion cells when it is included in ethylcellulose nanocapsules compared to a solution of melatonin. These outstanding findings add promising new perspectives to current knowledge about administrations using nano-technological tools in the treatment of neurodegenerative diseases at the ocular level.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.exer.2020.108222 | DOI Listing |
Life (Basel)
August 2025
Eye Clinic, Department of Neurosciences, Reproductive and Odontostomatological Sciences, University of Naples Federico II, 80131 Naples, Italy.
This case report presents a unique constellation of symptoms-including dry eye disease, visual and general asthenia, sleep disturbances, and restless legs syndrome-in a patient with a recent history of coronavirus disease 2019 (COVID-19) infection. While these symptoms have individually been associated with either COVID-19 or long COVID, their concurrent presentation and the simultaneous, positive response across all manifestations to a combined therapeutic regimen have not been previously described in a single case. The patient demonstrated notable improvement in both ocular and systemic symptoms following a six-week treatment with topical tear substitutes and oral administration of melatonin, and a multivitamin supplement including B-complex vitamins, antioxidants, and neuroprotective agents (Colinplus Delta, Farmaplus Italia Srl, Via Giovanni Porzio 4, 80143 Napoli, Italy).
View Article and Find Full Text PDFBiomolecules
July 2025
Department of Occupational and Environmental Health, School of Public Health, Jinzhou Medical University, Jinzhou 121001, China.
Developmental exposure to polybrominated diphenyl ethers (PBDEs), which are commonly used as flame retardants, results in irreversible cognitive impairments. Postnatal hippocampal neurogenesis, which occurs in the subgranular zone (SGZ) of the dentate gyrus, is critical for neuronal circuits and plasticity. Wnt7a-Frizzled5 (FZD5) is essential for both neurogenesis and synapse formation; moreover, Wnt signaling participates in PBDE neurotoxicity and also contributes to the neuroprotective effects of melatonin.
View Article and Find Full Text PDFJ Formos Med Assoc
August 2025
Department of Anesthesiology, Cathay General Hospital, Taipei, 106, Taiwan; National Defense Medical University, Institute of Medical Sciences, Taipei, 114, Taiwan. Electronic address:
Diabetes mellitus (DM), a global health issue, is a chronic metabolic disorder that mainly involves glucose homeostasis. It causes different complications, in particular, diabetic neuropathic pain (DNP). Pathophysiology of DM and DNP involves mitochondrial dysfunction, inflammation and oxidative stress.
View Article and Find Full Text PDFBMJ Open
August 2025
EGA Institute for Women's Health, University College London, London, UK
Introduction: Neonatal death and later disability remain common sequelae of hypoxic-ischaemic encephalopathy (HIE) despite the now standard use of therapeutic hypothermia (HT). New therapeutic approaches to brain protection are required. Melatonin is an indolamine hormone with free-radical scavenging, antiapoptotic, anti-inflammatory and gene regulatory neuroprotective properties, which has extensive preclinical evidence of safety and efficacy.
View Article and Find Full Text PDFEur J Med Chem
December 2025
Julius-Maximilians-Universität Würzburg (JMU), Institut für Pharmazie und Lebensmittelchemie, Pharmazeutische und Medizinische Chemie, Am Hubland, 97074, Würzburg, Germany. Electronic address:
In pursuit of developing advanced neuroprotective agents for neurodegenerative disorders, we rationally designed a series of novel hybrid molecules through structural integration of a vitamin K derivative with well-known antioxidants (ferulic acid, melatonin, α-lipoic acid, and Trolox, respectively). Systematic pharmacological evaluation revealed that most hybrids exhibited superior antioxidant activity in both DPPH radical scavenging and ORAC assays. Among these, a Trolox-vitamin K conjugate (compound 16e) emerged as a promising compound, demonstrating exceptional neuroprotective efficacy across multiple neuronal injury models, including oxytosis, ferroptosis, and ATP depletion in HT22 hippocampal neurons.
View Article and Find Full Text PDF